In this podcast episode, we discuss an important part of leadership – proactive behaviour. Or simply put—drive! As a statistician, your day-to-day approach to this topic will build up to long-term success. We discuss various aspects of the drive including: Never miss an episode of The Effective Statistician Join hundreds
Interview with Josephine Wolfram What is Real World Evidence (RWE) about? What is the perspective of the FDA on real world data and evidence? The FDA guidance contains 3 big topics – what are these? RWE is one of the most hot topics in the industry and the way the
In this episode, we share out ideas and experiences, which mindset sets up statisticians for success. We cover topics around: Never miss an episode of The Effective Statistician Join hundreds of your peers and subscribe to get our latest updates by email!Get the shownotes of our podcast episodes plus tips
Interview with Lina Eliasson How does patient adherence affect the results of clinical trials?Are there ways to improve patient adherence to medication and treatments not only in clinical trials but also in real-life situations?What is the future of the value of clinical trials in terms of inclusive technological innovations? Clinical
Interview with Liz Thompson Why would a person working under the rules and purpose of statistics for 30 years want something more than what she has been an expert with for many years? Do you want something more out of your statistician background? What could statisticians offer outside of the
Why should statisticians aim for becoming good leaders? How do you invest in yourself to become a good leader? How does perseverance change the path taken by a leader in the field of statistics? Gary Sullivan and I team up together to discuss the importance of leadership among statisticians. Understanding
Interview with Jenny Devenport Publications are part of the bigger communication plan which also covers PR, scientific dialog, promotion, training, and internal communications. Writing publications should follow an overall strategy for the compound or therapeutic area. They are necessary for further steps like having promotional material, HTA submissions, scientific/medical dialog,
What is a secondary paper? What is its typical content? Where is the content coming from? A secondary paper is a paper you do once you are done with your primary paper. I’ve been working on this for a long time and always have fun doing it. Together with Benjamin,
Feeling comfortable does not lead to growth. But why do most people stay in their comfort zone? Are your own expectations holding you back? In this episode, I am talking about the reasons why people stay in their comfort zones and always choose the “safe side”. And why choosing this
Interview with Claude Petit I am really passionate about leadership and Claude Petit is also passionate about building leaders and being an effective leader. Together, we will share with you how to become a statistical leader, how to build an organization of leaders, her very interesting leadership journey, and
Interview with Sree Kurup My experience of working with pharmacometricians was very limited because I spent most of my time working more on the later phases. The contact with people in pharmacology in the later phases of the industry is not that big. That’s why I found this episode really
What can go wrong with network meta-analyses? You often have multiple endpoints but these are not collected consistently across all the studies included in the NMA. How do you deal with this? Even with the same variables assessed over studies, they might be collected at different time points. This often
Never miss an episode of The Effective Statistician
Join hundreds of your peers and subscribe to get our latest updates by email!
Get the